We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

167 hedge funds and large institutions have $689M invested in Cardiovascular Systems, Inc. in 2017 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 55 increasing their positions, 50 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 12

20% more capital invested

Capital invested by funds: $576M → $689M (+$113M)

18% more funds holding

Funds holding: 142167 (+25)

10% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 50

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

68% less call options, than puts

Call options by funds: $204K | Put options by funds: $631K

Holders
167
Holders Change
+25
Holders Change %
+17.61%
% of All Funds
4.16%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
44
Increased
55
Reduced
50
Closed
12
Calls
$204K
Puts
$631K
Net Calls
-$427K
Net Calls Change
+$36K
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
126
T. Rowe Price Associates
Maryland
$248K -$319 -12 -0.1%
US Bancorp
127
US Bancorp
Minnesota
$246K +$29K +1,091 +14%
CANY
128
Caxton Associates (New York)
New York
$246K +$231K +8,691 New
GAM
129
Gotham Asset Management
New York
$239K +$225K +8,465 New
UBS AM
130
UBS AM
Illinois
$237K +$198K +7,470 +809%
CG
131
Caprock Group
Idaho
$237K
AG
132
Advisor Group
Arizona
$230K +$216K +8,130 New
KI
133
Koch Industries
Kansas
$229K +$215K +8,109 New
CSS
134
Cubist Systematic Strategies
Connecticut
$221K +$208K +7,816 New
WPC
135
White Pine Capital
Minnesota
$218K +$204K +7,700 New
Legal & General Group
136
Legal & General Group
United Kingdom
$215K -$7.41K -279 -4%
CG
137
Clinton Group
New York
$212K +$199K +7,486 New
PCM
138
Prelude Capital Management
New York
$209K -$86.2K -3,245 -31%
ZIM
139
Zacks Investment Management
Illinois
$205K +$193K +7,250 New
CCMW
140
Cypress Capital Management (Wyoming)
Wyoming
$173K -$5.71K -215 -3%
JP Morgan Chase
141
JP Morgan Chase
New York
$173K -$4.33M -162,979 -96%
JIM
142
Jupiter Investment Management
United Kingdom
$163K +$153K +5,770 New
WEC
143
Winslow Evans & Crocker
Massachusetts
$153K +$143K +5,400 New
QT
144
Quantbot Technologies
New York
$150K +$83K +3,126 +142%
AIM
145
Acrospire Investment Management
Illinois
$121K
Canada Life
146
Canada Life
Manitoba, Canada
$90K
TRCT
147
Tower Research Capital (TRC)
New York
$77K +$44.4K +1,670 +158%
AIP
148
Ameritas Investment Partners
Nebraska
$70K +$65.8K +2,478 New
Group One Trading
149
Group One Trading
Illinois
$64K +$60.3K +2,271 New
NIT
150
NumerixS Investment Technologies
British Columbia, Canada
$59K +$55.8K +2,100 New

CSII Hedge Fund Activity: Q1 2017 in Review

167 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q1 2017, worth a combined $689M — up 20% from $576M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new CSII positions and 12 closed out — a net gain of 32 holders — while 55 added to existing stakes and 50 trimmed.

The largest buyer was BlackRock, adding an estimated $62.4M. The largest seller was Granahan Investment Management, cutting an estimated $21.1M.

  • 167 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q1 2017, up from 142 in Q4 2016.
  • Funds reported $689M of Cardiovascular Systems, Inc. stock for Q1 2017, up 20% quarter-over-quarter.
  • 44 funds opened new Cardiovascular Systems, Inc. positions in Q1 2017 and 12 closed out, a net change of +32 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q1 2017 was BlackRock, an estimated $62.4M added.
  • The largest Cardiovascular Systems, Inc. seller in Q1 2017 was Granahan Investment Management, an estimated $21.1M sold.

Based on aggregated 13F filings for Q1 2017.